DEVELOPING A SAFE, NUTRITIONAL SUPPLEMENT FOR CHILDREN WITH DRY SKIN & ECZEMA

为干性皮肤儿童开发安全、营养的补充剂

• 批准号: 102942
• 金额: $ 23.5万
• 依托单位: CURAPEL (SCOTLAND) LIMITED
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2017
• 资助国家: 英国
• 起止时间: 2017 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=102942
• 关键词: DEVELOPING; SAFE; NUTRITIONAL; SUPPLEMENT; CHILDREN

Curapel® is a skin healthcare company that is developing patented products to help people with common, chronic and distressing skin conditions such as eczema and psoriasis. All Curapel's products contain natural and safe active ingredients which were identified by researchers at the the University of Manchester. The Curapel Philosophy is simple, we intend to develop successful products based on these technologies that work effectively with skin biology to 'Heal Skin Safely'. Eczema is one of the most common skin conditions that is six times more common in young children aged 1-5 years (~20%) than in adults (~3%). Unfortunately, current products for this distressing condition either just soothe the skin (emollients) or are medicines such as steroid creams that have extremely harsh side effects, especially when used by young children suffering from a chronic skin condition Curapel is now developing HISTIMEX as a safe, easy to use, once a day, oral nutritional supplement that provides a vital building block to restore a healthy skin barrier across the whole body. HISTIMEX has been tested in adults and has a similar effect as a middle-strength steroid cream but without any of the side effects. Curapel is now asking Innovate UK to help fund the testing of a new young child-friendly version of HISTIMEX in a clinical study in 1-5 year old children with eczema. When we have shown the effectiveness of this new children's HISTIMEX, we aim to launch it in 2017 as a safe product for young eczema sufferers.

Curapel®是一家皮肤保健公司，正在开发专利产品，以帮助患有湿疹和牛皮癣等常见、慢性和令人痛苦的皮肤病的人。所有Curapel的产品都含有天然和安全的活性成分，这些成分是由曼彻斯特大学的研究人员鉴定的。Curapel的理念很简单，我们打算开发基于这些技术的成功产品，这些技术有效地与皮肤生物学合作，以“安全地治愈皮肤”。湿疹是最常见的皮肤病之一，在1-5岁的幼儿中（约20%）比成人（约3%）多六倍。不幸的是，目前的产品，这种痛苦的条件，要么只是舒缓皮肤（润肤剂）或药物，如类固醇霜，具有极其苛刻的副作用，特别是当使用的幼儿患有慢性皮肤病Curapel现在开发HISTIMEX作为一个安全，易于使用，每天一次，口服营养补充剂，提供了一个重要的基石，以恢复整个身体的健康皮肤屏障。HISTIMEX已在成人中进行了测试，具有与中等强度类固醇霜相似的效果，但没有任何副作用。Curapel现在要求Innovate UK帮助资助在1-5岁湿疹儿童的临床研究中测试一种新的儿童友好型HISTIMEX。当我们展示了这种新的儿童HISTIMEX的有效性后，我们的目标是在2017年将其作为一种安全的产品推出，供年轻湿疹患者使用。